Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC)

Ann Oncol. 1997 Jul;8(7):695-6. doi: 10.1023/a:1008269432176.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Cyclobutanes / adverse effects
  • Cyclobutanes / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Organoplatinum Compounds / adverse effects
  • Organoplatinum Compounds / therapeutic use*
  • Thrombocytopenia / chemically induced
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Cyclobutanes
  • Organoplatinum Compounds
  • lobaplatin